It is becoming more common for athletes to be granted a therapeutic-use expemption for testerone by athletic commissions, but at UFC 162 was the first known case of an exemption for a different drug, this time a prescription opioid for Chris Leben:
The Nevada State Athletic Commission issued no new therapeutic-use exemptions for testosterone replacement therapy at UFC 162 but did give UFC middleweight Chris Leben permission to use the prescription opioid medication Suboxone.
Leben (22-10 MMA, 12-9 UFC), who lost a split decision to Andrew Craig (9-1 MMA, 3-1 UFC) at this past Saturday's event, is the first fighter to receive an exemption for the drug, which typically is used as a replacement therapy for people with narcotic dependency.
NSAC Executive Director Keith Kizer confirmed the news today with MMAjunkie.com (www.mmajunkie.com). Leben was unreachable for comment.
read entire article...
Related MMA gear from the UG Store